Literature DB >> 33118617

Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials.

Chia Siang Kow1, Mamoon Aldeyab2, Syed Shahzad Hasan2,3.   

Abstract

Entities:  

Year:  2020        PMID： 33118617     DOI： 10.1002/jmv.26638

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


× No keyword cloud information.
  5 in total

1.  Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios.

Authors:  Yawen Jiang; Dan Cai; Daqin Chen; Shan Jiang; Lei Si; Jing Wu
Journal:  Br J Clin Pharmacol       Date:  2021-05-05       Impact factor: 3.716

2.  Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials.

Authors:  Chih-Cheng Lai; Chao-Hsien Chen; Cheng-Yi Wang; Kuang-Hung Chen; Ya-Hui Wang; Po-Ren Hsueh
Journal:  J Antimicrob Chemother       Date:  2021-03-24       Impact factor: 5.790

3.  Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of Pakistan.

Authors:  Zia Ul Mustafa; Chia Siang Kow; Muhammad Salman; Mahpara Kanwal; Muhammad Bilal Riaz; Samina Parveen; Syed Shahzad Hasan
Journal:  Explor Res Clin Soc Pharm       Date:  2021-12-29

4.  V.I.T.A.M. in COVID 19: A Systematic Approach to a Global Pandemic.

Authors:  Siva Naga S Yarrarapu; Pankaj Bansal; David Abia-Trujillo; Austin Cusick; Megan Melody; Varun Moktan; Andrea Rivero; Tara J Brigham; Claudia Libertin; Lisa Brumble; J O'brein Jennifer; Augustine Lee; Torp Klaus; Christan Santos; Candido Rivera; Jason Siegel; Pramod Guru; Pablo Moreno Franco; Devang Sanghavi
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2021-10-04

Review 5.  The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19.

Authors:  Alessandro Bellis; Ciro Mauro; Emanuele Barbato; Bruno Trimarco; Carmine Morisco
Journal:  Int J Mol Sci       Date:  2020-11-15       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.